000			01942 a2200541 4500
005			20250516122848.0
264		0	_c20130503
008			201305s 0 0 eng d
022			_a1177-8881
024	7		_a10.2147/DDDT.S38008 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, Xinxin
245	0	0	_aLevodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats. _h[electronic resource]
260			_bDrug design, development and therapy _c2012
300			_a341-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xadministration & dosage
650	0	4	_aBenserazide _xadministration & dosage
650	0	4	_aBlotting, Western
650	0	4	_aDelayed-Action Preparations
650	0	4	_aDisease Models, Animal
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aDrug Carriers _xchemistry
650	0	4	_aDrug Combinations
650	0	4	_aDyskinesia, Drug-Induced _xetiology
650	0	4	_aFemale
650	0	4	_aLactic Acid _xchemistry
650	0	4	_aLevodopa _xadministration & dosage
650	0	4	_aMicrospheres
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPolyglycolic Acid _xchemistry
650	0	4	_aPolylactic Acid-Polyglycolic Acid Copolymer
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aReceptors, AMPA _xgenetics
700	1		_aChen, Yinghui
700	1		_aHong, Xiaoyun
700	1		_aWu, Na
700	1		_aSong, Lu
700	1		_aYuan, Weien
700	1		_aLiu, Zhenguo
773	0		_tDrug design, development and therapy _gvol. 6 _gp. 341-7
856	4	0	_uhttps://doi.org/10.2147/DDDT.S38008 _zAvailable from publisher's website
999			_c22295055 _d22295055